Business Wire

Novatus Global Secures $40 Million Growth Investment from Silversmith Capital Partners to Transform Transaction Reporting and Drive International Expansion Amid Complex Global Regulatory Environment

Share

Novatus Global Limited (“Novatus” or “the Company”), an award-winning provider of regulatory technology solutions to global financial institutions, today announced it has secured a $40 million investment from Silversmith Capital Partners, a Boston-based growth equity firm. Since its founding by industry veterans in 2019, Novatus has established itself as a trusted partner to many of the world’s largest banks, asset managers, and financial institutions – evidenced by revenue that has more than tripled over the trailing twelve months. The growth funding will enable Novatus to continue to invest deeply in the technology underpinning of its best-in-class SaaS platform while also expanding its geographic footprint, ensuring it maintains its reputation as the partner of choice for its clients.

Novatus enables its customers to meet their most complex, mission-critical regulatory and compliance requirements, be they government or industry-driven. Its flagship product, Novatus En:ACT, is a market-leading SaaS platform that ensures accurate, complete and timely reporting to satisfy the flood of ever-changing global regulations for which Novatus customers are responsible. En:ACT is a fully-scalable, cloud-native platform trusted by major global firms to reconcile both source systems and submission files and for all G20 transaction reporting regimes. In addition, Novatus offers expert-led advisory services, leveraging its SaaS solution and decades of industry experience, to help clients of all size and maturity solve their most complex compliance, risk management, ESG and organizational transformation challenges.

"We are delighted to partner with Silversmith as we embark on the next chapter of our growth journey. Silversmith shares our values and vision – particularly our passion for building great products to make our clients’ daily lives better, safer and more efficient,” said Novatus Co-Founder and Partner, Andrew Hedley. “This investment will be used to double down on that commitment to innovation while also fueling our continued international expansion, particularly in North America following our successful entry into Australia last year. It is a real privilege to work with such brilliant people across our team and we are incredibly excited for the next chapter of growth."

“When we founded the company in 2019, we had a leg up on the market – Andrew and I had both lived this problem first-hand. As a result, we wanted to provide a solution that would solve the complexity of transaction reporting in a novel way – driven by powerful, automated underlying technology as opposed to human intervention,” added Novatus Co-Founder and Partner, Matthew Ranson. “With deep experience in the GRC and regtech markets, Silversmith recognized the uniqueness of En:ACT in attacking the problem with fresh eyes and harnessing the massive innovation being driven by AI and machine learning. We look forward to working closely with Todd, Ned and the Silversmith team to achieve our vision of creating the single best platform of its type anywhere in the world.”

“At Silversmith, our investment philosophy is quite simple to articulate, though much more difficult to implement – identify great founders who have built solutions to real-life customer problems. While company building takes enormous effort and will, we’ve found over time that if you get that first part right, the rest tends to take care of itself,” said Ned Kingsley, Principal at Silversmith. “We feel incredibly lucky to have found two such individuals in Andrew and Matt who have re-imagined the way to solve an increasingly important customer problem. We couldn’t be more excited to support their continued growth alongside Maven Capital Partners.”

“We are excited to continue our partnership with Novatus following the investment from Silversmith. We were originally attracted to the business due to its innovative, and technology-led approach in supporting clients meet their regulatory obligations,” said Alan Robertson, Partner at Maven.“Since Maven’s initial investment, clients’ adoption of the En:ACT platform has resulted in a 13-fold increase in annual recurring revenues and international expansion. We remain committed to supporting Novatus as they scale globally and further enhance their market-leading platform to continue to deliver for its clients. We believe in the future potential of the business and look forward to working with both Management and Silversmith in helping achieve the Company’s ambitions.”

As a part of the investment, Todd MacLean and Ned Kingsley have joined Novatus’ Board of Directors. Wilson Sonsini Goodrich & Rosati acted as legal counsel to Novatus on the transaction. Kirkland & Ellis served as legal counsel to Silversmith Capital Partners and KPMG served as financial advisors. Burness Paull acted as legal counsel to Maven Capital Partners.

About Novatus Global Limited

Novatus Global, established in 2019 and headquartered in London, is a leading global provider of software and strategic advisory services, enabling the world’s largest financial institutions to navigate their most complex regulatory and strategic challenges. Our expertise spans transaction reporting, risk, compliance, ESG, strategy, and data, delivering solutions that drive operational excellence and demonstrable regulatory compliance.

Our award-winning SaaS platform, Novatus En:ACT, enables firms to ensure accurate, complete, and timely transaction reporting across all global reporting regimes. Novatus Global pairs cutting-edge technology with unparalleled industry knowledge, ensuring clients meet evolving regulatory demands and mitigate risk effectively.

We are trusted by global institutions to meet their mission critical obligations, transform their transaction reporting, streamline operations, and achieve sustainable growth in an increasingly complex regulatory landscape.

About Silversmith Capital Partners

Founded in 2015, Silversmith Capital Partners is a Boston-based growth equity firm with $3.3 billion of capital under management. Silversmith’s mission is to partner with and support the best entrepreneurs in growing, profitable technology and healthcare companies. Representative investments include ActiveCampaign, Appfire, Apryse, DistroKid, impact.com, Iodine Software, LifeStance Health, Onbe, and Webflow. For a full list of portfolio investments, visit www.silversmith.com. Follow the firm on LinkedIn.

About Maven Capital Partners UK LLP

Maven is one of the UK’s leading private equity firms, specialising in investments in high growth British companies. With a focus on innovation and value creation, Maven partners with visionary entrepreneurs to build market leading businesses, supporting a range of transaction types, including management buyouts, growth capital, buy and build projects, equity value release and pre-IPO financing. www.mavencp.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240912506446/en/

Contacts

Carolyn Kostelny
ckostelny@novatus.global

Kate Castle
kate@silversmith.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release

Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release

The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th

Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release

Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor

Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release

Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not

BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye